Nattokinase-Promoted Tissue Plasminogen Activator Release from Human Cells
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
When heated to a temperature of 70°C or higher, the strong fibrinolytic activity of nattokinase in a solution was deactivated. Similar results were observed in the case of using Suc-Ala-Ala-Pro-Phe-pNA and H-D-Val-Leu-Lys-pNA, which are synthetic substrates of nattokinase. In the current study, tests were conducted on the indirect fibrinolytic effects of the substances containing nattokinase that had been deactivated through heating at 121°C for 15 min. Bacillus subtilis natto culture solutions made from three types of bacteria strain were heat-treated and deactivated, and it was found that these culture solutions had the ability to generate tissue plasminogen activators (tPA) from vascular endothelial cells and HeLa cells at certain concentration levels. For example, it was found that the addition of heat-treated culture solution of the Naruse strain (undiluted solution) raises the tPA activity of HeLa cells to about 20 times that of the control. Under the same conditions, tPA activity was raised to a level about 5 times higher for human vascular endothelial cells (HUVEC), and to a level about 24 times higher for nattokinase sold on the market. No change in cell count was observed for HeLa cells and HUVEC in the culture solution at these concentrations, and the level of activity was found to vary with concentration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nattokinase has direct in vitro [123] and in vivo [124] fibrinolytic activity, in addition to increasing tissue plasminogen activator [125] and reducing platelet aggregation [126].”
From Fermented foods: definitions and characteristics, impact on the gut microbiota and effects on gastrointestinal health and disease (2019) · cites this paper as [125]
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
The fibrin plate method for estimating fibrinolytic activity
Astrup, T., & Müllertz, S. (1952) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(52)90121-5 · Cited by 1,692
A study of proteases and protease-inhibitor complexes in biological fluids
Granelli-Piperno, A., & Reich, E. (1978) · The Journal of Experimental Medicine · doi:10.1084/jem.148.1.223 · Cited by 803
Wang, Y. F., Tsirka, S. E., Strickland, S., Stieg, P. E., Soriano, S. G., & Lipton, S. A. (1998) · Nature Medicine · doi:10.1038/nm0298-228 · Cited by 630
Sumi, H., Hamada, H., Tsushima, H., Mihara, H., & Muraki, H. (1987) · Experientia · doi:10.1007/bf01956052 · Cited by 570
Self-citationStatistical Methods for Research Workers.
Jowett, G. H., & Fisher, R. A. (1956) · Applied Statistics · doi:10.2307/2985747 · Cited by 516
Enhancement of the Fibrinolytic Activity in Plasma by Oral Administration of Nattokinases
Sumi, H., Hamada, H., Nakanishi, K., & Hiratani, H. (1990) · Acta Haematologica · doi:10.1159/000205051 · Cited by 304
Self-citationMedcalf, R. L., Rüegg, M., & Schleuning, W. D. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77347-x · Cited by 133
Matys, T., Pawlak, R., Matys, E., Pavlides, C., McEwen, B. S., & Strickland, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407355101 · Cited by 111
Waller, E. K., & Schleuning, W. D. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)88979-7 · Cited by 72
Research works printed but not linked: 1
- 10.1006%2Fabio.1987.9999 · doi:10.1006/abio.1987.9999 · Paper page
Cited by
Dimidi, E., Cox, S., Rossi, M., & Whelan, K. (2019) · Nutrients · doi:10.3390/nu11081806 · Cited by 801
“Nattokinase has direct in vitro [123] and in vivo [124] fibrinolytic activity, in addition to increasing tissue plasminogen activator [125] and reducing platelet aggregation [126].”
BackgroundNattokinase: An Oral Antithrombotic Agent for the Prevention of Cardiovascular Disease
Weng, Y., Yao, J., Sparks, S., & Wang, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030523 · Cited by 192
Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases
Chen, H., McGowan, E. M., Ren, N., Lal, S., Nassif, N., Shad-Kaneez, F., Qu, X., & Lin, Y. (2018) · Biomarker Insights · doi:10.1177/1177271918785130 · Cited by 168
Fermented foods: An update on evidence-based health benefits and future perspectives
Diez-Ozaeta, I., & Astiazaran, O. J. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111133 · Cited by 162
Fermented Soy Products and Their Potential Health Benefits: A Review
do Prado, F. G., Pagnoncelli, M. G. B., Pereira, G. V. D. M., Karp, S. G., & Soccol, C. R. (2022) · Microorganisms · doi:10.3390/microorganisms10081606 · Cited by 187
Nattokinase: production and application
Dabbagh, F., Negahdaripour, M., Berenjian, A., Behfar, A., Mohammadi, F., Zamani, M., Irajie, C., & Ghasemi, Y. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-6135-3 · Cited by 138
“It not only degrades fibrin directly but also increases the release of tissue plasminogen activator from cells to degrade fibrin (Yatagai et al. 2008).”
BackgroundQiao, Y., Zhang, K., Zhang, Z., Zhang, C., Sun, Y., & Feng, Z. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111575 · Cited by 133
Role of Fibrinolytic Enzymes in Anti-Thrombosis Therapy
Altaf, F., Wu, S., & Kasim, V. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.680397 · Cited by 118
“It works by directly degrading the fibrin and plasmin substrate, transforms pro-urokinase into uPA, hydrolyses PAI-1 and enhance the level of tPA, which facilitate fibrinolytic activity (Sumi, et al., 1987; Yatagai et al., 2007; Chen et al., 2018).”
BackgroundCai, D., Wei, X., Qiu, Y., Chen, Y., Chen, J., Wen, Z., & Chen, S. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13175 · Cited by 74
Biotechnology, Bioengineering and Applications of Bacillus Nattokinase
Li, Y., Chen, L., Tang, X., & Li, J. (2022) · Biomolecules · doi:10.3390/biom12070980 · Cited by 78
Microbial production of nattokinase: current progress, challenge and prospect
Cai, D., Zhu, C., & Chen, S. (2017) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-017-2253-2 · Cited by 62
“It could not only degrade fibrin directly, but also stimulates the cells to release the tissue plasminogen activator, which further contributes to fibrin degradation (Yatagai et al. 2008).”
BackgroundVersatility of subtilisin: A review on structure, characteristics, and applications
Azrin, N. A. M., Ali, M. S. M., Rahman, R. N. Z. R. A., Oslan, S. N., & Noor, N. D. M. (2022) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2309 · Cited by 69
Natto: A medicinal and edible food with health function
Wang, C., Chen, J., Tian, W., Han, Y., Xu, X., Ren, T., Tian, C., & Chen, C. (2023) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2023.02.005 · Cited by 52
Recent Advances in Nattokinase-Enriched Fermented Soybean Foods: A Review
Li, D., Hou, L., Hu, M., Gao, Y., Tian, Z., Fan, B., Li, S., & Wang, F. (2022) · Foods · doi:10.3390/foods11131867 · Cited by 56
“the level of t-PA (tissue plasminogen activator) and inhibits the level of PAI-1 (plasminogen activator inhibitor) [11,12].”
BackgroundDwivedi, S., Singh, V., Sharma, K., Sliti, A., Baunthiyal, M., & Shin, J. (2023) · Plant Foods for Human Nutrition · doi:10.1007/s11130-023-01130-1 · Cited by 61
Yanagisawa, Y., Chatake, T., Chiba-Kamoshida, K., Naito, S., Ohsugi, T., Sumi, H., Yasuda, I., & Morimoto, Y. (2010) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309110043137 · Cited by 50
Self-citationWei, X., Luo, M., Xie, Y., Yang, L., Li, H., Xu, L., & Liu, H. (2012) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-012-9894-2 · Cited by 40
Takabayashi, T., Imoto, Y., Sakashita, M., Kato, Y., Tokunaga, T., Yoshida, K., Narita, N., Ishizuka, T., & Fujieda, S. (2017) · Allergology International · doi:10.1016/j.alit.2017.03.007 · Cited by 43
Yan, G., Min, S., Wei, S., Ma, L., Chao, Z., Yaping, W., & Zunxi, H. (2021) · BMC Biotechnology · doi:10.1186/s12896-021-00708-4 · Cited by 39
“Histological examination was carried out as previously described [8, 9, 33].”
MethodEnzyme-Based Anti-Inflammatory Therapeutics for Inflammatory Diseases
Narayanan, K. B. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17050606 · Cited by 50
“…and tissue It also activates other fi brino-lytic enzymes, such as pro-urokinase and tissue plasminogen activator [72,73]. plasminogen activator [72,73] Figure 5C illustrates the catalytic triad of nattokinase, comprising Ser221, Figure 5C illustrates the catalytic triad of na tt okinase,…”
Use of Exogenous Enzymes in Human Therapy: Approved Drugs and Potential Applications
Cioni, P., Gabellieri, E., Campanini, B., Bettati, S., & Raboni, S. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210713094722 · Cited by 35
Data Recorded in Real Life Support the Safety of Nattokinase in Patients with Vascular Diseases
Gallelli, G., Mizio, G. D., Palleria, C., Siniscalchi, A., Rubino, P., Muraca, L., Cione, E., Salerno, M., Sarro, G. D., & Gallelli, L. (2021) · Nutrients · doi:10.3390/nu13062031 · Cited by 31
“The fibrinolytic activity of nattokinase is related to a complex mechanism of action: the enzyme [1] breaks down blood clots by directly hydrolyzing fibrin and plasmin; [2] converts endogenous pro-urokinase to urokinase; [3] degrades plasminogen activator inhibitor-1, and [4] increases tissue plasminogen activator [1–…”
BackgroundNattokinase: Structure, applications and sources
Jamali, N., Vahedi, F., Fard, E. S., Taheri‐Anganeh, M., Taghvimi, S., Khatami, S. H., Ghasemi, H., & Movahedpour, A. (2022) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2022.102564 · Cited by 26
Zhou, X., Liu, L., & Zeng, X. (2021) · Food Structure · doi:10.1016/j.foostr.2021.100219 · Cited by 27
Yao, M., Yang, Y., Fan, J., Ma, C., Liu, X., Wang, Y., Wang, B., Sun, Z., McClements, D. J., Zhang, J., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2134980 · Cited by 28
“On one hand, NK could promote the conversion of prourokinase to urokinase, together with stimulating vascular endothelial cells to produce t-PA, thus activate plasminogen to plasmin (Yatagai et al. 2008).”
BackgroundLi, Y., Tang, X., Chen, L., Xu, X., & Li, J. (2022) · Foods · doi:10.3390/foods11162403 · Cited by 23
Wei, X., Luo, M., & Liu, H. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.01.034 · Cited by 21
Nailufar, F., Tjandrawinata, R. R., & Suhartono, M. T. (2016) · Advances in Pharmacological Sciences · doi:10.1155/2016/4206908 · Cited by 21
“For internal standard using beta actin gene, they were 5GAGTCAACGGATTTGGTCG-3 and 5-TCGCTGTTG AAG TCA GAG GA-3 as forward and reverse primers [16].”
MethodGranito, M., Alvarenga, L., Ribeiro, M. M., Carvalhosa, P., Andrade, T., Mesquita, C. T., Stockler‐Pinto, M. B., Mafra, D., & Cardozo, L. (2024) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2024.2416663 · Cited by 24
“The decrease in plasma levels of fibrinogen, factor VII, and factor VIII is another characteristic that makes NK a viable nutraceutical for treating CVD [36].”
X-ray structure determination and deuteration of nattokinase
Yanagisawa, Y., Chatake, T., Naito, S., Ohsugi, T., Yatagai, C., Sumi, H., Kawaguchi, A., Chiba-Kamosida, K., Ogawa, M., Adachi, T., et al. (2013) · Journal of Synchrotron Radiation · doi:10.1107/s0909049513020700 · Cited by 16
Self-citationGrixti, J. M., Theron, C. W., Salcedo-Sora, J. E., Pretorius, E., & Kell, D. B. (2024) · Journal of Experimental and Clinical Application of Chinese Medicine · doi:10.62767/jecacm504.6557 · Cited by 17
High-efficiency heterologous expression of nattokinase based on a combinatorial strategy
Gu, Z., Ning, C., Liu, Z., Liang, Q., Fu, X., Tian, M., Zhu, C., & Mou, H. (2023) · Process Biochemistry · doi:10.1016/j.procbio.2023.08.008 · Cited by 13
Unsaturated fatty acids enhance the fibrinolytic activity of subtilisin NAT (nattokinase)
Takagaki, S., Suzuki, M., Suzuki, E., & Hasumi, K. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13326 · Cited by 15
Wu, H., Zhang, Q., Suo, H., Xu, F., Huang, W., & Wang, D. O. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250198 · Cited by 15
Shi, Y., Liu, C., Gui, Y., Guo, Y., Zhang, Y., Pan, J., Tang, H., Gao, C., Xing, J., Han, Y., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402763 · Cited by 10
Probiotic Properties of Exopolysaccharide-Producing Bacteria from Natto
Ngampuak, V., Thongmee, A., Pongpoungphet, N., Wongwailikhit, K., & Kanchanaphum, P. (2023) · International Journal of Food Science · doi:10.1155/2023/3298723 · Cited by 16
“Nattokinase has direct in vitro [24] and in vivo [25] fi brinolytic enzyme activity, increasing tissue plasminogen activators [26] and reducing platelet aggregation [27].”
BackgroundNaik, S. V., Katariya, R., Shelke, S., Patravale, V. B., Umekar, M. J., Kotagale, N. R., & Taksande, B. G. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175821 · Cited by 11
Li, X., Long, J., Gao, Q., Pan, M., Wang, J., Yang, F., & Zhang, Y. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2408234 · Cited by 14
“Oral administration of nattokinase not only promotes the release of tissue plasminogen activator from vascular endothelial cells, but inhibits the level of plasminogen activator inhibitors [10,11].”
BackgroundVI.A. Pharmacologic Vitreolysis
Sebag, J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1086-1_47 · Cited by 10
Combined Computer-Aided Predictors to Improve the Thermostability of Nattokinase
Li, Y., Chen, L., Tang, X., Zhu, W., Ma, A., Shi, C., & Li, J. (2023) · Foods · doi:10.3390/foods12163045 · Cited by 8
Safety assessment of subtilisin QK in rats
Xiao, S., Hu, D., Gao, Y., Ai, Y., Luo, S., Chen, S., Wang, B., Zhou, L., Dong, Y., & Wang, Y. (2021) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-021-00506-w · Cited by 6
Safety of fermented soybean extract NSK‐SD® as a novel food pursuant to Regulation (EC) No 258/97
EFSA Panel on Dietetic Products, N. A. A. (. (2016) · EFSA Journal · doi:10.2903/j.efsa.2016.4541 · Cited by 12
Wang, L.-X., Meng, J., Yu, X., Wang, J., Zhang, Y., Zhang, M., Zhang, Y., Wang, H., Feng, H., Tian, Q., et al. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.110126 · Cited by 6
Optimization of Liquid Fermentation Conditions and Encapsulation for Nattokinase Production
Zhou, H. M., Zhang, H. X., Xie, Y., Zhou, T., Liu, H., & Luo, Y. B. (2013) · Advanced materials research · doi:10.4028/www.scientific.net/amr.781-784.1403 · Cited by 5
Mining and Modification of Key Functional Regions of the Nattokinase Propeptide
Ma, A., Wang, H., Jia, H., Yu, S., Zhu, W., Yu, K., Ma, Y., Li, Y., & Li, J. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c09651 · Cited by 4
Maggot Kinase and Natural Thrombolytic Proteins
Liu, C., Zhang, K., Zhang, S., Li, X., Sun, H., & Ma, L. (2024) · ACS Omega · doi:10.1021/acsomega.4c01663 · Cited by 3
Effect of nattokinase on the pathological conditions in streptozotocin induced diabetic rats
Yamaguchi, M., Fukuyama, R., & Fujita, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28835 · Cited by 3
Nattokinase: A hope in cardiovascular therapy and more
EFESC, F., & IONESCU, D.-D. (2020) · Romanian Journal of Medical Practice · doi:10.37897/rjmp.2020.3.2 · Cited by 2
“273 de urokinază din prourokinază, stimularea t-PA (tissue plasminogen activator) ce generează plasmină din plasminogen și inhibiția PAI-1 (plasminogen activation inhibitor 1) prin proteoliză; există și dovezi experimentale că nattokinaza este capabilă să degradeze direct fibrina din trombi [3-7].”
BackgroundZhang, K., Zhang, X., Wang, A., Zhong, W., Pei, Y., Jin, H., Zhou, Z., Chen, C., Wang, S., & Lou, M. (2025) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2025.108511 · Cited by 2
Acute and Subchronic Toxicities and Safety Pharmacology Studies of a Bacillus Subtilisin in Dogs
Xiao, S., Dong, Y., Hu, K., Hu, D., Zhou, L., & Wang, Y. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00659 · Cited by 3
Molecular Structure of Functional Proteins and Their Properties in the SandwormPreprint
Song, T., Cheng, J., Ye, S., & Wu, W. (2024) · Preprints.org · doi:10.20944/preprints202402.0210.v1 · Cited by 1
Kajian Enzim Fibrinolitik pada Mikroorganisme Asal Pangan Fermentasi Asia: Review
Syahbanu, F., & Pawestri, S. (2023) · Jurnal Teknologi Hasil Pertanian · doi:10.20961/jthp.v16i1.72623 · Cited by 4
NATTOKINASE – USES AND BENEFITS
Hristova, M. (2023) · Trakia Journal of Sciences · doi:10.15547/tjs.2023.04.007
Recent Advances in Fermented Functional Foods
Mohedano, M. L., Zarour, K., Diez‐Ozaeta, I., Dueñas, M. T., López, P., & Russo, P. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781837673292-00030 · Cited by 1
Additional file 1 of Safety assessment of subtilisin QK in rats
Xiao, S., Hu, D., Gao, Y., Ai, Y., Luo, S., Chen, S., Wang, B., Zhou, L., Dong, Y., & Wang, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14850622
Guangbo, Y., Min, S., Wei, S., Lixin, M., Chao, Z., Yaping, W., & Zunxi, H. (2021) · Figshare · doi:10.6084/m9.figshare.15139436
Therapeutics Applications of Nattokinase and Collagenases
Sharma, V., & Sharma, S. (2026) · Springer eBooks · doi:10.1007/978-981-95-4941-2_5
Advances in Nattokinase Research: Therapeutic Potential and Applications
Li, M., Wang, P., CHENG, M., Deng, X., Xizhong, S. O. N. G., & Weng, M. (2026) · Wuhan University Journal of Natural Sciences · doi:10.1051/wujns/2026312166
Zhao, J. Y., Gao, J., Ma, Y., Li, H., Zhang, K. C., Li, Y., Liu, X., Song, Y., & Deng, Y. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04648-z
“It exhibits biological activity primarily through its capacity to selectively recognize and hydrolyze cross-linked fibrin without degrading plasma fibrinogen, thereby serving as a safe thrombolytic agent in vivo [25].”
Metadata
- Authors
- Yatagai, C., Maruyama, M., Kawahara, T., & Sumi, H.
- Affiliations
- University of Miyazaki (JP)
- Kurashiki University of Science and the Arts (JP)
- Venue
- Pathophysiology of Haemostasis and Thrombosis
- Publisher
- S. Karger AG
- Published
- 2007
- Volume
- 36
- Issue
- 5
- Pages
- 227-232
- ISSN
- 1424-8832 (ISSN-L)
- 1424-8840
- OpenAlex
- W2057183366
- Cited by
- 59
- References
- 18
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 7 · 2023: 10 · 2022: 9 · 2021: 8 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 3 · 2014: 3 · 2013: 2 · 2012: 1
- FWCI
- 0.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Pathophysiology of Haemostasis and Thrombosis (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Enzyme Production and Characterization
- Keywords
- nattokinase, tissue plasminogen activator, thermal inactivation, fibrinolysis, Bacillus natto, vascular endothelial cells, HeLa cells, fibrinolytic activity
- MeSH terms
- Bacillus subtilis, Cells, Cultured, Endothelium, Vascular, Fibrinolytic Agents, Hot Temperature, HeLa Cells, Humans, Tissue Plasminogen Activator, Subtilisins, Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.